Rocket Pharmaceuticals Inc

RCKTNASDAQ · USD
2.61USD0.00 (+0.58%)
137

Rocket Pharmaceuticals Inc (RCKT) Option Chain

As of September 28, 2026, Rocket Pharmaceuticals Inc is trading at $2.61, a +0.58% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 73.0%. IV Rank is 6%.

Read more

Tracking the RCKT option chain helps you see every strike and expiry on Rocket Pharmaceuticals Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Rocket Pharmaceuticals Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of RCKT options activity at a glance. Use our scanner to monitor the RCKT option chain in real time and filter for the RCKT options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For RCKT stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the RCKT option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where RCKT stock options are being actively traded and where they are not.

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia.

The company also has a clinical stage in vivo adeno-associated virus program for Danon disease, a multi-organ lysosomal-associated disorder leading to early death due to heart failure. It has license agreements with Fred Hutchinson Cancer Research Center; Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Centro de Investigacion Biomedica En Red, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; CIEMAT and UCL Business PLC; The Regents of the University of California; and REGENXBIO, Inc. Rocket Pharmaceuticals, Inc. is headquartered in Cranbury, New Jersey.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Rocket Pharmaceuticals Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen RCKT options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of RCKT stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile7.94% Subdued
  • Market cap (M$)287
  • 52 weeks high-52.11%
  • 52 weeks low3.16%
  • Analyst recommendationBuy
    2.29
  • Target price$8.85
    239.08% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-05
  • P/E—
  • Future P/E—
  • EPS (ttm)-0.18
  • EPS growth next 5 years18.72%

As of September 28, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
42.09417150.090.110.100.302.50-4.21—0.200.000.20025257.91
100.006,694100.100.00—0.105.00+91.571.802.902.39-0.040870.00
100.001,09500.600.00—0.607.50+187.364.305.504.890.01010.00
100.0013200.100.00—0.1010.00+283.146.708.207.390.06000.00

As of September 28, 2026

Scan the full option chain in one place

Browse the full RCKT option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial